GLP-1 vs Exendin-4

Head-to-head comparison of GLP-1 (Glucagon-like peptide-1 (7-36 amide)) and Exendin-4 (Exendin-4 (synthetic exenatide)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyGLP-1Exendin-4
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameGlucagon-like peptide-1 (7-36 amide)Exendin-4 (synthetic exenatide)
Molecular Weight3297 Da4186 Da
Half-Life1-2 minutes2.4 hours
Amino Acids3039
Typical DoseResearch-only: 0.1-1.0 pmol/kg/min5-10 mcg twice daily
RouteIntravenous/SubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count12001800
Research StatusPre-clinicalClinical

GLP-1 Benefits

  • beta-cell protection
  • improved insulin secretion
  • slower gastric emptying
  • lower postprandial glucose

Exendin-4 Benefits

  • beta-cell survival
  • glucose-stimulated insulin secretion
  • reduced glucolipotoxicity
  • lowered HbA1c in clinical use

GLP-1 Dosing

0.1-1.0 pmol/kg/min IV infusion in research|0.5-10 nM in vitro|continuous delivery in animal studies

Exendin-4 Dosing

5 mcg SC twice daily for 4 weeks|increase to 10 mcg SC twice daily if tolerated|research: 0.1-1 µM in vitro or 1-10 µg/kg in animals

GLP-1 Side Effects

  • nausea at pharmacologic exposure
  • tachyphylaxis with continuous exposure
  • headache

Exendin-4 Side Effects

  • nausea
  • vomiting
  • injection-site reactions

Research Overview

GLP-1

Native GLP-1 has a very short half-life because of rapid DPP-4 cleavage, so it is mainly used as a mechanistic research peptide. Across animal and cellular studies it reduces beta-cell apoptosis, improves insulin gene expression, and enhances islet resilience.

Exendin-4

Exendin-4 helped establish GLP-1 receptor biology in diabetes and remains a classic beta-cell protective peptide. Preclinical studies show reduced beta-cell apoptosis, improved insulin content, and better islet function under metabolic stress.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

GLP-1 stacks with:

DPP-4 inhibitorsSGLT2 inhibitorsdiet and exercise

Exendin-4 stacks with:

SGLT2 inhibitorsDPP-4 inhibitorsdiet and exercise
incretinbeta-cell survivalDPP-4 substrateGLP-1 agonistbeta-cell protection